Duckworth Reacts to Supreme Court Decision to Preserve Access to Mifepristone

[WASHINGTON, D.C.] – U.S. Senator Tammy Duckworth (D-IL) issued the following statement after the Supreme Court decided to restore access to mifepristone—a medication that the Food and Drug Administration (FDA) first approved in 2000, and which doctors have safely and effectively prescribed for more than 20 years until a Trump Judge’s extreme and unprecedented decision to overturn a long-standing FDA drug-approval for the first time in our nation’s history:  

“This was the right decision—anything short of preserving access to this FDA-approved drug would have set a dangerous new precedent where one rogue, extremely far-right judge could strip away access to a safe and effective medication for millions of Americans. 

“Make no mistake: this isn’t over—this legal case is still pending. And Republicans will continue looking for ways to ban access to abortion for women across every state and take away the freedom to decide what’s best for their bodies and families. 

“The Biden Administration should continue to use every tool at its disposal to ensure this medication remains widely available, and Congress should immediately enshrine the right to choose into federal law.”  

-30-

• Print
• Tweet